Emi Yamazaki

13PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsAllergyAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 03, 2026
Cutaneous Squamous Cell Carcinoma Arising From Hidradenitis Suppurativa and Epidermal Cyst: Clinical Characteristics, Baseline Neutrophil-To-Lymphocyte Ratio, and Disease-Specific Survival in a Retrospective Cohort.

|Oct 28, 2025
Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration.

Emi Yamazaki, Taku Fujimura, Yumi Kambayashi

|Mar 25, 2025
Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment.

Ryo Amagai, Taku Fujimura, Yumi Kambayashi

|Jan 25, 2025
Impact of Hyaluronic Acid on the Cutaneous T-Cell Lymphoma Microenvironment: A Novel Anti-Tumor Mechanism of Bexarotene.

Tetsuya Ikawa, Emi Yamazaki, Ryo Amagai

|Jun 04, 2024
A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trial.

Taku Fujimura, Koji Yoshino, Hiroshi Kato

|Feb 17, 2022
Characterization of rosacea patients in Tohoku area of Japan: Retrospective study of 340 rosacea cases.

Moyuka Wada-Irimada, Haruka Yamamoto, Hitoshi Terui

Pageof 3

Frequent Collaborators

8 joint publications

Taku Fujimura

8 joint publications

Yoshihide Asano

7 joint publications

Yumi Kambayashi

5 joint publications

Ryo Amagai